Authors: Carroll, P Coley, C McLeod, D Schellhammer, P Sweat, G Wasson, J Zietman, A Thompson, I

Citation: P. Carroll et al., Prostate-specific antigen best practice policy - part I: Early detection and diagnosis of prostate cancer, UROLOGY, 57(2), 2001, pp. 217-224

Authors: Carroll, P Coley, C McLeod, D Schellhammer, P Sweat, G Wasson, J Zietman, A Thompson, I

Citation: P. Carroll et al., Prostate-specific antigen best practice policy - part II: Prostate cancer staging and post-treatment follow-up, UROLOGY, 57(2), 2001, pp. 225-229

Authors: Zietman, AL Thakral, H Wilson, L Schellhammer, P

Citation: Al. Zietman et al., Conservative management of prostate cancer in the prostate specific antigen era: The incidence and time course of subsequent therapy, J UROL, 166(5), 2001, pp. 1702-1706

Authors: Schellhammer, P Fabozzi, S

Citation: P. Schellhammer et S. Fabozzi, Testicular androgen ablation for prostate cancer, UROLOGY, 54(1), 1999, pp. 194-194